Parexel International Corp. (NSDQ:PRXL) brought the number of its offices in Japan to three with the addition of a new office in Nagoya.
The Waltham, Mass.-based clinical research organization established the new location to prop up its clinical development and regulatory consulting operations both in the Land of the Rising Sun and the Asia-Pacific region.
In addition to the trio of Japanese offices, Parexel now has 18 offices in the region, including those in Australia, China, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand, according to a press release.
In May, the company opened two offices in Chengdu and Guangzhou, China.
MassDevice published an update on the regulatory climate in Asia today that includes new information about Japan’s reimbursement program.